The effects of FK 506 on cytokine production are dependent on the mode of cell activation.
Andersson
J
J
Department of Immunology, Stockholm University, Sweden.
Nagy
S
S
Groth
C G
CG
Andersson
U
U
D000906:Antibodies; D015703:Antigens, CD / Q000276:immunology; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D018106:CD28 Antigens; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis*; D004305:Dose-Response Relationship, Drug; D004768:Enterotoxins / Q000494:pharmacology; D004926:Escherichia coli; D006801:Humans; D015759:Ionomycin / Q000494:pharmacology; D007700:Kinetics; D008070:Lipopolysaccharides; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D013211:Staphylococcus aureus; D016559:Tacrolimus / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D000906:Antibodies; D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D018106:CD28 Antigens; D016207:Cytokines; D004768:Enterotoxins; D008070:Lipopolysaccharides; C026066:enterotoxin A, Staphylococcal; D015759:Ionomycin; D013755:Tetradecanoylphorbol Acetate; D016559:Tacrolimus